SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001493152-24-023802
Filing Date
2024-06-14
Accepted
2024-06-14 09:56:44
Documents
1
Period of Report
2024-06-13

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 3112
  Complete submission text file 0001493152-24-023802.txt   4679
Mailing Address 3150 ALMADEN EXPRESSWAY, SUITE 250 SAN JOSE CA 95118
Business Address 3150 ALMADEN EXPRESSWAY, SUITE 250 SAN JOSE CA 95118 408-708-9808
Anixa Biosciences Inc (Issuer) CIK: 0000715446 (see all company filings)

IRS No.: 112622630 | State of Incorp.: DE | Fiscal Year End: 1031
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 6 AUTUMN LANE SARATOGA SPRINGS NY 12866
Business Address
Titterton Lewis H jr (Reporting) CIK: 0001499254 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37492 | Film No.: 241043343